SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Global Health Ltd (MEDANTA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543654 NSE: MEDANTA Hospital & Healthcare Services | Small Cap | Global Health Share Price

₹1,239.50 9.60 (0.78%)

As on 05-Jun'26 16:59

Global Health Ltd (MEDANTA)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543654 NSE: MEDANTA Hospital & Healthcare Services | Small Cap | Global Health Share Price

₹1,239.50 9.60 (0.78%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹33,068 Cr.
Current Price
₹1,239.5
52-Week Low / High
₹955 / 1,456
TTM EPS
₹18.5
TTM Sales
₹3,709 Cr.
Book Value per Share
₹149.6
P/E Ratio
66.64
In line with its 5-year historical median
Industry PE
87
Price to Book (P/B)
8.22
In line with its 5-year historical median
Price to Sales (P/S)
8.91
Lower than its 5-year historical median
EV/EBITDA
37.68
In line with its 5-year historical median
Dividend Yield
0.04%
Profitability Efficiency
Return on Equity (ROE)
14.14%
In line with industry median
Return on Capital Employed (ROCE)
19.25%
Outperforms industry median
Return on Assets (ROA)
9.12%
Operating Profit Margin
23.3%
Net Profit Margin
14.4%
Gross Profit Margin
25.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
40.53%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-0.83%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-5.1%
Asset Quality
Promoter Holding
33.01%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹3,967 Cr.
Equity
₹53.8 Cr.
Face Value
₹2
All Time Low / High
₹391.05 / 1513.75

Global Health stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Global Health Ltd a good quality company?
Global Health Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Global Health Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Global Health Ltd vs industry peers?
Global Health Ltd revenue CAGR is 16.83%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Global Health Ltd?
Promoters hold 33.01% of the Global Health Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Global Health Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 28.91% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Global Health Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ26.4%8.9%6.8%8.3%11.3%7.7%19.5%17.2%24.3%19.3%-
Value Creation
Index ⓘ		1.4-0.2-0.4-0.30-0.30.40.31.20.7-

Growth Parameters ⓘ
Sales ⓘ1,3821,2771,3431,4411,4721,2271,7651,9742,2803,2043,709
Sales YoY Gr.--7.6%5.2%7.3%2.2%-16.6%43.8%11.8%15.5%40.5%-
Adj EPS ⓘ7.22.31.62.64.12.38.69.913.418.518.5
YoY Gr.--68.4%-32.3%69.7%57.4%-44.7%276.9%14.5%35.8%37.6%-
BVPS (₹) ⓘ42.544.44649.954.457.268.592.6105.9130.2149.6
Adj Net
Profit ⓘ		17655.537.564.710256.8219265360496496
Cash Flow from Ops. ⓘ22812480.1152193201235431341528-
Debt/CF from Ops. ⓘ0.61.52.10.90.10.10.50.20.20.3-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ9.8%16.8%22%40.5%
Adj EPS ⓘ11%34.9%28.9%37.6%
BVPSⓘ13.3%19.1%23.9%22.9%
Share Price - - 26.6% 1.9%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		1853.25.17.53.913.612.513.515.213.2
Op. Profit
Mgn % ⓘ		22.1109.710.114.914.121.621.522.123.320.4
Net Profit
Mgn % ⓘ		12.74.32.84.56.94.612.413.415.815.513.4
Debt to
Equity ⓘ		0.10.20.20.1000.10000.1
Working Cap
Days ⓘ		425465738015415816719316877
Cash Conv.
Cycle ⓘ		-9-359510984850

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales1,3821,2771,3431,4411,4721,2271,7651,9742,9753,204
Operating Expenses ⓘ + 1,0771,1511,2131,2971,2541,0541,3841,5522,2222,457
Manufacturing Costs5593139182170206294342530587
Material Costs363285313325314298441459700759
Employee Cost 472519527541522416495533677744
Other Costs ⓘ 187253234250248135155218315367
Operating Profit ⓘ 305127130144219173381422753747
Operating Profit Margin (%) 22.1%9.9%9.7%10.0%14.8%14.1%21.6%21.4%25.3%23.3%
Other Income ⓘ + 456749654428354891116
Exceptional Items ⓘ 000000000-50
Interest ⓘ 14232821332933325141
Depreciation ⓘ 6981869199888786134150
Profit Before Tax ⓘ 26890649713184296352659623
Tax ⓘ 9235273428277788173162
Profit After Tax 17655376310357219263486462
PAT Margin (%) 12.7%4.3%2.8%4.4%7.0%4.7%12.4%13.3%16.4%14.4%
Adjusted EPS (₹)7.32.31.52.64.22.38.69.818.117.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%2.90%

Valuation of Global Health - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 1,0571,1091,1481,2581,3741,4511,7342,4843,0333,497
Share Capital ⓘ 81818182828251545454
Reserves ⓘ 9761,0281,0671,1771,2921,3691,6842,4302,9793,444
Debt +12416214811518198958131114
Long Term Debt11313212311518198958131114
Short Term Debt1130250000000
Minority Interest0000000000
Trade Payables92104106126118109103142162169
Others Liabilities ⓘ 2232883072594978389271,0701,4261,587
Total Liabilities ⓘ 1,4961,6641,7091,7582,0082,4182,8543,7544,7515,367

Fixed Assets

Net Fixed Assets ⓘ +9139729288699298518278101,6451,861
Gross Block1,2131,1261,1671,1981,3501,3541,4101,4722,4912,842
Accumulated Depreciation300154239329421502583663847981
CWIP ⓘ 1187534675280458
Investments ⓘ 1400356501626734765362366
Inventories28212323323240425549
Trade Receivables75107152164148130173173214292
Cash Equivalents 3714692532402192554411,1451,1371,053
Others Assets ⓘ 84863461011755216327441,0581,290
Total Assets ⓘ 1,4961,6641,7091,7582,0082,4182,8543,7544,7515,367

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 22812480152193201235431559528
PBT ⓘ 26890649713184296352659623
Adjustment ⓘ 7610712210512210510083128155
Changes in Working Capital ⓘ -18-14-523-426-6996-53-90
Tax Paid ⓘ -97-58-53-67-56-15-91-101-174-161
Cash Flow From Investing Activity ⓘ + -245-112-46-104-45-250-313-257-519-638
Capex -156-90-49-29-17-23-64-115-224-557
Net Investments 0-48-233696-117-162-145-248-124
Others ⓘ -892625-111-124-111-873-4742
Cash Flow From Financing Activity ⓘ + -7-6-36-49-56-3798404-379-94
Net Proceeds from Shares ⓘ 1001003847900
Net Proceeds from Borrowing ⓘ 00-8-6-16-098-34-312-57
Interest Paid ⓘ -11-17-23-18-23-21-24-25-57-28
Dividend Paid ⓘ 0000000000
Others ⓘ 411-5-25-16-15-14-16-11-9
Net Cash Flow ⓘ -246-2-192-8620577-339-205

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)18.765.243.415.3884.1513.8812.4817.6314.14
ROCE (%)26.398.896.788.2911.37.6919.5117.2324.2719.25
Asset Turnover Ratio1.020.810.80.830.780.550.670.60.70.63
PAT to CFO Conversion(x)1.32.252.162.411.873.531.071.641.151.14
Working Capital Days
Receivable Days172635.104038.8041.4031.303223.7028.80
Inventory Days7765.806.909.507.407.6065.90
Payable Days87.90125.80122.60130.50142.10139.3087.9097.7079.4079.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Global Health Ltd FAQs

The current trading price of Global Health on 05-Jun-2026 16:59 is ₹1,239.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Global Health stood at ₹33,068.1 Cr

The latest P/E ratio of Global Health as of 04-Jun-2026 is 66.64.

The latest P/B ratio of Global Health as of 04-Jun-2026 is 8.22.

The 52-week high of Global Health is ₹1,455.9 and the 52-week low is ₹955.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Global Health is ₹3,709 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Global Health Ltd is a good quality company.

The key valuation ratios of Global Health Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Global Health Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Global Health Ltd

The company was incorporated as ‘Global Health Private Limited’ on August 13, 2004 at New Delhi, India as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation by the Registrar of Companies, Delhi and Haryana at Delhi (RoC). The company was then converted into a public limited company under the Companies Act, 2013, pursuant to a special resolution passed by its Shareholders at the EGM held on July 31, 2021 and consequently, the name of the Company was changed to ‘Global Health Limited’ and a fresh certificate of incorporation dated August 11, 2021 was issued by the RoC.

The company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity and operating revenues amongst the players that operate in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology. Under the “Medanta” brand, the company has a network of many hospitals currently in operation (Gurugram, Indore, Ranchi, Lucknow and Patna) and one hospital (Noida), which is under construction. The company strives to deliver advanced healthcare by establishing institutes of excellence that integrate medical care, teaching and research all while providing affordable medical services to patients.

Business area of the company

Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Key awards, accreditations, certifications and recognitions

Accreditations

  • 2011: 1st National Accreditation Board for Hospitals and Healthcare Providers (“NABH”) accreditation for the hospital at Gurugram
  • 2011: 1st National Accreditation Board for Testing and Calibration Laboratories accreditation for the hospital at Gurugram.
  • 2013: 1st Joint Commission International (JCI) accreditation for the hospital at Gurugram
  • 2014: 1st NABH (blood bank) accreditation for the hospital at Gurugram.
  • 2016: 1st NABH accreditation for the hospital at Indore.
  • 2018: 1st NABH accreditation for the hospital at Ranchi.
  • 2020: 1st NABH accreditation for the Medanta Institutional Ethics Committee at the hospital at Gurugram.
  • 2022: 1st NABH accreditation for the hospital at Lucknow.

Awards

  • 2020: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the top 200 global hospitals by Newsweek.
  • 2021: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2021: Hospital at Gurugram featured in the list of world’s best specialised hospitals for cardiology by Newsweek.
  • 2021: Hospital at Gurugram awarded ‘Best Multi-Speciality Hospital – National’ at ‘The Economic Times Healthcare Awards, 2021’.
  • 2021: Hospital at Gurugram ranked as the best multi-specialty private hospital in North India by The Week.
  • 2021: Hospital at Gurugram was ranked first for emergency, neurology, gynaecology, and ranked second for cardiology, gastroenterology, nephrology, oncology and urology by The Times of India’s Critical Care Study 2021.
  • 2022: Hospital at Gurguram featured in the list of world’s best specialised hospitals for cardiology and neurology by Newsweek.
  • 2022: Hospital at Gurugram featured in the top 250 global hospitals by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best private hospital in India by Newsweek.
  • 2022: Hospital at Gurugram ranked as the best multi-speciality private hospital in North India and the second best private hospital in India as per Best All India Multi Speciality Hospital Ranking 2022 by Outlook and NEB Research.

Major Events:

  • 2009: Establishment and commencement of operations of Medanta – the Medicity Hospital at Gurugram.
  • 2010: Leased premises for clinic at the Indira Gandhi International Airport, New Delhi.
  • 2010: Leased premises for clinic at Defence Colony, New Delhi.
  • 2013: Anant Investments (i.e., Investor Selling Shareholder) invested in Company.
  • 2013: Leased premises for clinic at DLF Cybercity.
  • 2014: Entered into a 27-year lease for hospital at Indore.
  • 2015: Dunearn Investments (Mauritius) Pte Ltd invested in Company.
  • 2015: Entered into a 15-year lease for hospital at Ranchi.
  • 2015: GHPPL entered into a 33-year concession agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna.
  • 2016: Entered into a 90-year lease for a proposed hospital at Noida.
  • 2019: Commencement of operations of new hospital at Lucknow by MHPL.
  • 2020: Gurugram hospital outpatient department pharmacy taken in-house.
  • 2020: Launch of outpatient department at hospital at Patna by GHPPL.
  • 2021: Lucknow hospital outpatient department pharmacy taken in-house.
  • 2021: Indore hospital outpatient department pharmacy taken in-house.
  • 2021: Ranchi hospital outpatient department pharmacy taken in-house.
  • 2021: Launch of outpatient department pharmacy at south Delhi clinic.
  • 2022: Patna hospital’s inpatient department facility commenced operations.
  • 2022: Launch of Patna hospital outpatient department pharmacy.
  • 2022: Leased premises for clinic at Subhash Chowk.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×